JAZZ Annual EBIT
$587.37 M
+$671.91 M+794.76%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual earnings before interest & taxes is $587.37 million, with the most recent change of +$671.91 million (+794.76%) on December 31, 2023. During the last 3 years, it has risen by +$212.56 million (+56.71%). JAZZ annual EBIT is now -3.39% below its all-time high of $1.23 billion.JAZZ EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly EBIT
$259.51 M
+$59.56 M+29.79%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly earnings before interest & taxes is $259.51 million, with the most recent change of +$59.56 million (+29.79%) on September 30, 2024. Over the past year, it has increased by +$88.49 million (+51.75%). JAZZ quarterly EBIT is now at all-time high.JAZZ Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ TTM EBIT
$655.82 M
+$88.49 M+15.60%
30 September 2024
Summary:
As of January 22, 2025, JAZZ TTM earnings before interest & taxes is $655.82 million, with the most recent change of +$88.49 million (+15.60%) on September 30, 2024. Over the past year, it has increased by +$466.17 million (+245.81%). JAZZ TTM EBIT is now -10.00% below its all-time high of $728.67 million, reached on March 31, 2021.JAZZ TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +794.8% | +51.8% | +245.8% |
| 3 y3 years | +56.7% | +51.8% | +245.8% |
| 5 y5 years | -3.4% | +51.8% | +245.8% |
JAZZ EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +794.8% | at high | +197.6% | at high | +875.7% |
| 5 y | 5-year | at high | +794.8% | at high | +197.6% | -10.0% | +875.7% |
| alltime | all time | -3.4% | +517.8% | at high | +197.6% | -10.0% | +442.9% |
Jazz Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $259.51 M(+29.8%) | $655.82 M(+15.6%) |
| June 2024 | - | $199.95 M(+209.9%) | $567.33 M(+8.6%) |
| Mar 2024 | - | $64.51 M(-51.1%) | $522.63 M(-11.0%) |
| Dec 2023 | $587.37 M(-794.8%) | $131.85 M(-22.9%) | $587.37 M(+209.7%) |
| Sept 2023 | - | $171.01 M(+10.2%) | $189.65 M(+389.4%) |
| June 2023 | - | $155.25 M(+20.1%) | $38.75 M(-220.0%) |
| Mar 2023 | - | $129.25 M(-148.6%) | -$32.30 M(-61.8%) |
| Dec 2022 | -$84.54 M(-151.0%) | -$265.87 M(-1421.8%) | -$84.54 M(-137.6%) |
| Sept 2022 | - | $20.11 M(-76.1%) | $225.09 M(-2.4%) |
| June 2022 | - | $84.20 M(+9.3%) | $230.72 M(+188.8%) |
| Mar 2022 | - | $77.01 M(+75.9%) | $79.88 M(-51.9%) |
| Dec 2021 | $165.93 M(-55.7%) | $43.77 M(+70.1%) | $165.93 M(-43.7%) |
| Sept 2021 | - | $25.74 M(-138.6%) | $294.54 M(-36.6%) |
| June 2021 | - | -$66.64 M(-140.9%) | $464.37 M(-36.3%) |
| Mar 2021 | - | $163.06 M(-5.4%) | $728.67 M(+94.4%) |
| Dec 2020 | $374.80 M(-28.8%) | $172.38 M(-11.9%) | $374.80 M(+43.4%) |
| Sept 2020 | - | $195.57 M(-1.1%) | $261.44 M(+32.1%) |
| June 2020 | - | $197.66 M(-203.6%) | $197.94 M(-2.3%) |
| Mar 2020 | - | -$190.81 M(-423.3%) | $202.63 M(-61.5%) |
| Dec 2019 | $526.56 M(-13.4%) | $59.01 M(-55.3%) | $526.56 M(-19.3%) |
| Sept 2019 | - | $132.07 M(-34.7%) | $652.34 M(-7.9%) |
| June 2019 | - | $202.35 M(+52.0%) | $708.29 M(+8.1%) |
| Mar 2019 | - | $133.13 M(-28.0%) | $655.02 M(+7.7%) |
| Dec 2018 | $607.96 M(+17.2%) | $184.79 M(-1.7%) | $607.96 M(+7.9%) |
| Sept 2018 | - | $188.02 M(+26.1%) | $563.53 M(+22.6%) |
| June 2018 | - | $149.08 M(+73.2%) | $459.74 M(-2.2%) |
| Mar 2018 | - | $86.08 M(-38.7%) | $470.28 M(-9.4%) |
| Dec 2017 | $518.87 M(-12.7%) | $140.35 M(+66.6%) | $518.87 M(-5.5%) |
| Sept 2017 | - | $84.23 M(-47.2%) | $548.97 M(-8.4%) |
| June 2017 | - | $159.62 M(+18.5%) | $599.60 M(-1.5%) |
| Mar 2017 | - | $134.68 M(-21.0%) | $608.72 M(+2.4%) |
| Dec 2016 | $594.39 M(+20.6%) | $170.44 M(+26.4%) | $594.39 M(+11.6%) |
| Sept 2016 | - | $134.87 M(-20.1%) | $532.66 M(+0.8%) |
| June 2016 | - | $168.74 M(+40.2%) | $528.35 M(+6.9%) |
| Mar 2016 | - | $120.34 M(+10.7%) | $494.19 M(+0.3%) |
| Dec 2015 | $492.85 M(+141.3%) | $108.72 M(-16.7%) | $492.85 M(-4.5%) |
| Sept 2015 | - | $130.56 M(-3.0%) | $516.05 M(+14.7%) |
| June 2015 | - | $134.57 M(+13.1%) | $450.02 M(+15.4%) |
| Mar 2015 | - | $119.00 M(-9.8%) | $389.81 M(+90.8%) |
| Dec 2014 | $204.27 M | $131.92 M(+104.5%) | $204.27 M(+23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $64.52 M(-13.2%) | $165.88 M(-17.6%) |
| June 2014 | - | $74.36 M(-211.8%) | $201.31 M(+0.7%) |
| Mar 2014 | - | -$66.54 M(-171.1%) | $199.87 M(-40.3%) |
| Dec 2013 | $334.87 M(+72.4%) | $93.53 M(-6.4%) | $334.87 M(+9.3%) |
| Sept 2013 | - | $99.95 M(+37.0%) | $306.45 M(+17.5%) |
| June 2013 | - | $72.93 M(+6.5%) | $260.71 M(+14.9%) |
| Mar 2013 | - | $68.46 M(+5.1%) | $226.96 M(+16.8%) |
| Dec 2012 | $194.22 M(+53.4%) | $65.12 M(+20.1%) | $194.24 M(+16.6%) |
| Sept 2012 | - | $54.20 M(+38.3%) | $166.64 M(+14.9%) |
| June 2012 | - | $39.19 M(+9.6%) | $145.05 M(+3.8%) |
| Mar 2012 | - | $35.74 M(-4.7%) | $139.72 M(+10.4%) |
| Dec 2011 | $126.58 M(+178.2%) | $37.51 M(+15.0%) | $126.58 M(+23.7%) |
| Sept 2011 | - | $32.61 M(-3.7%) | $102.32 M(+21.6%) |
| June 2011 | - | $33.86 M(+49.8%) | $84.15 M(+38.2%) |
| Mar 2011 | - | $22.60 M(+70.6%) | $60.88 M(+33.8%) |
| Dec 2010 | $45.50 M(+185.6%) | $13.25 M(-8.3%) | $45.50 M(+4.2%) |
| Sept 2010 | - | $14.44 M(+36.5%) | $43.66 M(+32.6%) |
| June 2010 | - | $10.58 M(+46.4%) | $32.93 M(+8.4%) |
| Mar 2010 | - | $7.23 M(-36.6%) | $30.38 M(+90.7%) |
| Dec 2009 | $15.93 M(-111.3%) | $11.41 M(+207.6%) | $15.93 M(-191.4%) |
| Sept 2009 | - | $3.71 M(-53.8%) | -$17.44 M(-64.3%) |
| June 2009 | - | $8.03 M(-211.2%) | -$48.89 M(-53.0%) |
| Mar 2009 | - | -$7.22 M(-67.1%) | -$104.02 M(-26.0%) |
| Dec 2008 | -$140.60 M(+1.3%) | -$21.96 M(-20.9%) | -$140.60 M(-20.7%) |
| Sept 2008 | - | -$27.74 M(-41.1%) | -$177.39 M(+5.9%) |
| June 2008 | - | -$47.09 M(+7.5%) | -$167.44 M(+2.7%) |
| Mar 2008 | - | -$43.81 M(-25.4%) | -$163.10 M(+17.5%) |
| Dec 2007 | -$138.78 M(+77.8%) | -$58.74 M(+230.1%) | -$138.78 M(-27.4%) |
| Sept 2007 | - | -$17.80 M(-58.4%) | -$191.27 M(+18.2%) |
| June 2007 | - | -$42.75 M(+119.4%) | -$161.80 M(+50.7%) |
| Mar 2007 | - | -$19.48 M(-82.5%) | -$107.37 M(+37.6%) |
| Dec 2006 | -$78.05 M(+36.6%) | -$111.23 M(-1052.9%) | -$78.05 M(+94.9%) |
| Sept 2006 | - | $11.67 M(0.0%) | -$40.04 M(-13.6%) |
| June 2006 | - | $11.67 M(+18.7%) | -$46.35 M(-12.0%) |
| Mar 2006 | - | $9.84 M(-113.4%) | -$52.67 M(-7.8%) |
| Dec 2005 | -$57.14 M(+130.4%) | -$73.23 M(-1465.9%) | -$57.14 M(-455.3%) |
| Sept 2005 | - | $5.36 M(0.0%) | $16.08 M(+50.0%) |
| June 2005 | - | $5.36 M(0.0%) | $10.72 M(+100.0%) |
| Mar 2005 | - | $5.36 M | $5.36 M |
| Dec 2004 | -$24.80 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual EBIT year-on-year change?
- What is Jazz Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly EBIT year-on-year change?
- What is Jazz Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM EBIT year-on-year change?
What is Jazz Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of JAZZ is $587.37 M
What is the all time high annual EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual earnings before interest & taxes is $1.23 B
What is Jazz Pharmaceuticals annual EBIT year-on-year change?
Over the past year, JAZZ annual earnings before interest & taxes has changed by +$671.91 M (+794.76%)
What is Jazz Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of JAZZ is $259.51 M
What is the all time high quarterly EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly earnings before interest & taxes is $259.51 M
What is Jazz Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, JAZZ quarterly earnings before interest & taxes has changed by +$88.49 M (+51.75%)
What is Jazz Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of JAZZ is $655.82 M
What is the all time high TTM EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM earnings before interest & taxes is $728.67 M
What is Jazz Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, JAZZ TTM earnings before interest & taxes has changed by +$466.17 M (+245.81%)